Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 16

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 16
---
 concurrently with step (a) above, the Warrant outstanding immediately prior to the Effective Time shall,                                                                                                                                                  
 notwithstanding the terms of such Warrant and any subscription or similar agreement pursuant to which such Warrant was issued, be deemed to be transferred and surrendered by such holder to the Company, and such Warrant shall immediately be cancelled 
 and all of the Company’s obligations with respect to such Warrant shall be deemed to be fully satisfied. For greater certainty, because the exercise price in respect of such Warrant is greater than the Cash Amount, neither the Company nor the        
 Purchaser shall be obligated to pay the holder of such Warrant the Consideration or any other amount in respect of such Warrant, and such Warrant shall be immediately cancelled and surrendered for no consideration. In addition, (i) the former        
 holder of the Warrant shall cease to be a holder of such Warrant, (ii) such holder’s name shall be removed from the register of Warrants, (iii) the Warrant agreement and any and all subscription or similar agreements relating to the                  
 Warrant shall be terminated and shall be of no further force and effect and (iv) such holder shall cease to have any rights as a holder in respect of such Warrant;                                                                                       |

| f) | each Common Share outstanding immediately prior to the Effective Time held by a Dissenting Shareholder shall be                                                                                                                                   
 deemed to have been transferred (free and clear of all Encumbrances), without any further act or formality by or on behalf of any Dissenting Shareholder, to the Purchaser, in consideration for a debt claim against the Purchaser for an amount 
 determined under Article 3 of the Plan of Arrangement, and:                                                                                                                                                                                       |

| (i) | such Dissenting Shareholder shall cease to be the registered holder of such Common Share and to have any rights                            
 as a Shareholder other than the right to be paid the Fair Value by the Purchaser for such Common Share set out in the Plan of Arrangement; |

| (ii) | such Dissenting Shareholder’s name shall be removed as the registered holder of Common Shares from the 
 applicable register of Shareholders maintained by or on behalf of the Company; and                     |

| (iii) | the Purchaser shall be deemed to be the transferee of such Common Shares free and clear of all Encumbrances and 
 shall be entered in the register of the Shareholders maintained by or on behalf of the Company;                 |

| g) | each Common Share